NXP Semiconductors N.V. (NASDAQ: NXPI) today announced it is strengthening its European research and development (R&D) through grants to be provided via the 2nd Important Project of Common European Interest onNXP Semiconductors N.V.
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.31) per share. This is a 93.75 percent decrease over losses of $(0.16) per share from the same period last year.